Inventor · disambiguated record
Arnaud Foussat
Also filed as: FOUSSAT ARNAUD
5 granted patents·17 pending applications·11 citations·filing 2004–2023
70Inventor score
Top patents by PatentIndex Score
22 records- 0173US7977093B2Obtention of food- or auto-antigen specific TR1 cells from a leukocyte or PBMC populationINST NAT SANTE RECH MED·Filed 2006·Granted Jul 12, 2011·3 cites·39 claims
- 0267US7771932B1Method for identification of Tr1 lymphocytes regulators by the presence and over-expression of specific molecules and application thereofTXCELL·Filed 2004·Granted Aug 10, 2010·8 cites·30 claims
- 0355US8992907B2Compositions for treating an intestinal inflammatory conditionFOUSSAT ARNAUD·Filed 2008·Granted Mar 31, 2015·0 cites·20 claims
- 0454US9517253B2Compositions for treating multiple sclerosisFOUSSAT ARNAUD·Filed 2008·Granted Dec 13, 2016·0 cites·9 claims
- 0550US2011038844A1Compositions for treating an arthritic conditionTXCELL·Filed 2009·Application pending·0 cites
- 0650US2025179175A1Anti-cd160 transmembrane isoform antibodiesALDERAAN BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 0749US2025026722A1Substituted quinolines as improved nf-kb-inducing kinase (nik) inhibitorsYukin Therapeutics·Filed 2022·Application pending·0 cites
- 0848US2011052535A1Compositions for treating an inflammatory autoimmune conditionTXCELL·Filed 2009·Application pending·0 cites
- 0944US2022251232A1Novel anti-cd25 antibodiesINSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICAL·Filed 2020·Application pending·0 cites
- 1043US2007275005A1Use of Lipopeptides for Activating T Lymphocytes Through the SkinINST NAT SANTE RECH MED·Filed 2004·Application pending·0 cites
- 1142US2015064206A1Compositions for treating uveitisFOUSSAT ARNAUD·Filed 2014·Application pending·0 cites
- 1241US2018250372A1Compositions for treating an arthritic conditionTXCELL·Filed 2018·Application pending·0 cites
- 1340US2010247577A1Tr1 cells, mesenchymal stem cells and uses thereofTXCELL·Filed 2008·Application pending·0 cites
- 1438US8815534B2Method for assessing the efficacy of a TR1 cell therapy in a subjectFOUSSAT ARNAUD·Filed 2011·Granted Aug 26, 2014·0 cites·11 claims
- 1538US2009104142A1Compositions for treating multiple sclerosisTXCELL·Filed 2007·Application pending·0 cites
- 1636US2017042992A1Compositions for treating multiple sclerosisTXCELL·Filed 2016·Application pending·0 cites
- 1731US2015306143A1Compositions for treating an inflammatory autoimmune conditionTXCELL·Filed 2015·Application pending·0 cites
- 1831US2015157707A1Compositions for treating an intestinal inflammatory conditionTXCELL·Filed 2015·Application pending·0 cites
- 1931US2014044687A1Method for using regulatory t cells in therapyFORTE MIGUEL·Filed 2011·Application pending·0 cites
- 2026US2011311590A1Compositions for treating an allergic or asthmatic conditionFOUSSAT ARNAUD·Filed 2010·Application pending·0 cites
- 2124US2013101568A1Il-13 producing tr1-like cells and use thereofFOUSSAT ARNAUD·Filed 2011·Application pending·0 cites
- 2224US2013034528A1New methods for isolating tr1 cellsTXCELL·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →